RIG 200 is an S-nitrosothiol nitric oxide ( NO ) donor. RIG 200 releases NO through decomposition, activating guanylate cyclase ( sGCM ) in vascular smooth muscle cells, increasing cGMP levels, and leading to vasodilation. RIG 200 significantly inhibits Collagen ( HY-NP003 )-induced platelet aggregation in platelet-rich plasma (PRP). RIG 200 may be used in research on antithrombus.
Products | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > Guanylate Cyclase | Products > Signaling Pathways > NO Synthase
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.